Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Terazosin in Dementia With Lewy Bodies
NCT04760860Phase 2Not yet recruiting
- Start
- Oct 2027
- Primary completion
- Oct 2030
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of terazosin in dementia with Lewy bodies (DLB). Planned start Oct 2027; status: not yet recruiting.
02
Drugs
terazosin
03
Conditions
dementia with Lewy bodies (DLB)
Beyond the preview
Go deeper on NCT04760860.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04760860.